Evidence map›Paper›PMID 35645324›Full record

ArticlePathophysiology : the official journal of the International Society for Pathophysiology2022

Transthoracic Echocardiography-Based Prediction Model of Adverse Event Risk in Patients with COVID-19.

Elena Zelikovna Golukhova, Inessa Viktorovna Slivneva, Maxim Leonidovich Mamalyga, Damir Ildarovich Marapov, Mikhail Nikolaevich Alekhin, Mikhail Mikhailovich Rybka, Irina Vasilevna Volkovskaya

Open access · goldAbstract read
In one paragraph

Article in Pathophysiology : the official journal of the International Society for Pathophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Elena Zelikovna GolukhovaA.N. Bakulev National Medical Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Inessa Viktorovna SlivnevaDepartment of Emergency Ultrasound and Functional Diagnostics, A.N. Bakulev National Medical Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.ORCID 0000-0001-7935-7093
Maxim Leonidovich MamalygaDepartment of Surgical Treatment of Coronary Heart Disease, A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Damir Ildarovich MarapovDepartment of Public Health, Economics and Health Care Management, Kazan State Medical Academy-Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation, 420012 Kazan, Russia.
Mikhail Nikolaevich AlekhinFunctional Diagnostics Department of the Central Clinical Hospital with Polyclinic of the Russian Presidential Administration, 121359 Moscow, Russia.ORCID 0000-0002-9725-7528
Mikhail Mikhailovich RybkaDepartment of Anesthesiology and Intensive Care, A.N. Bakulev National Medical Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Irina Vasilevna VolkovskayaPolyclinic Department of the Institute of Coronary and Vascular Surgery, A.N. Bakulev National Medical Scientific Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, 121552 Moscow, Russia.
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences · RUCentral Clinical Hospital and Polyclinic · RURussian Medical Academy of Continuous Professional Education · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiopulmonary disorders cause a significant increase in the risk of adverse events in patients with COVID-19. Therefore, the development of new diagnostic and treatment methods for comorbid disorders in COVID-19 patients is one of the main public health challenges. The aim of the study was to analyze patient survival and to develop a predictive model of survival in adults with COVID-19 infection based on transthoracic echocardiography (TTE) parameters. We conducted a prospective, single-center, temporary hospital-based study of 110 patients with moderate to severe COVID-19. All patients underwent TTE evaluation. The predictors of mortality we identified in univariate and multivariable models and the predictive performance of the model were assessed using receiver operating characteristic (ROC) analysis and area under the curve (AUC). The predictive model included three factors: right ventricle (RV)/left ventricle (LV) area (odds ratio (OR) = 1.048 per 1/100 increase, p = 0.03), systolic pulmonary artery pressure (sPAP) (OR = 1.209 per 1 mm Hg increase, p < 0.001), and right ventricle free wall longitudinal strain (RV FW LS) (OR = 0.873 per 1% increase, p = 0.036). The AUC-ROC of the obtained model was 0.925 ± 0.031 (95% confidence interval (95% CI): 0.863−0.986). The sensitivity (Se) and specificity (Sp) measures of the models at the cut-off point of 0.129 were 93.8% and 81.9%, respectively. A binary logistic regression method resulted in the development of a prognostic model of mortality in patients with moderate and severe COVID-19 based on TTE data. It may also have additional implications for early risk stratification and clinical decision making in patients with COVID-19.

Indexed as

COVID-19multivariable modelpredictive modelright ventricle free wall longitudinal strainsystolic pulmonary artery pressuretransthoracic echocardiographyTTE

Identifiers

PMID35645324
PMCPMC9149931
OpenAlexW4224927643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.